Efficacy and safety of bioresorbable vascular scaffold over a period of 3 years


eMediNexus    24 February 2018

It is known that the Absorb bioresorbable vascular scaffold (BVS) completely resorbs within 3 years after coronary artery implantation. An individual-patient-data pooled meta-analysis of 4 randomized ABSORB trials was performed to evaluate the efficacy and safety of BVS through this 3-year period. Patients with coronary artery disease were randomly allocated to receive either everolimus-eluting Absorb BVS or cobalt-chromium everolimus-eluting stents. The findings published in the Circulation journal showed that BVS was associated with increased rates of target lesion failure and device thrombosis between 1 and 3 years and cumulatively through 3 years of follow-up in comparison to everolimus-eluting stents.

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.